These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10468958)
1. Apoptosis in neuroendocrine tumours. Wang DG Clin Endocrinol (Oxf); 1999 Jul; 51(1):1-9. PubMed ID: 10468958 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis regulating genes in neuroendocrine tumors. Liu WH; Wang DG Histol Histopathol; 2000 Jul; 15(3):851-9. PubMed ID: 10963129 [TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53. Wang DG; Johnston CF; Sloan JM; Buchanan KD J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375 [TBL] [Abstract][Full Text] [Related]
4. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis. Wang DG; Liu WH; Johnston CF; Sloan JM; Buchanan KD Am J Pathol; 1998 Jun; 152(6):1407-13. PubMed ID: 9626044 [TBL] [Abstract][Full Text] [Related]
5. Expression of the apoptosis-suppressing gene BCL-2 in pheochromocytoma is associated with the expression of C-MYC. Wang DG; Johnston CF; Marley JJ; Phenix KV; Atkinson AB; Russell CF; Buchanan KD J Clin Endocrinol Metab; 1997 Jun; 82(6):1949-52. PubMed ID: 9177412 [TBL] [Abstract][Full Text] [Related]
6. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. Raha P; Thomas S; Thurn KT; Park J; Munster PN Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915 [TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc. Wang DG; Johnston CF; Atkinson AB; Heaney AP; Mirakhur M; Buchanan KD J Clin Pathol; 1996 Oct; 49(10):795-7. PubMed ID: 8943742 [TBL] [Abstract][Full Text] [Related]
8. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma. Taylor AC; Schuster K; McKenzie PP; Harris LC Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823 [TBL] [Abstract][Full Text] [Related]
10. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. Reed JC; Miyashita T; Takayama S; Wang HG; Sato T; Krajewski S; Aimé-Sempé C; Bodrug S; Kitada S; Hanada M J Cell Biochem; 1996 Jan; 60(1):23-32. PubMed ID: 8825412 [TBL] [Abstract][Full Text] [Related]
11. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Reed JC Semin Hematol; 1997 Oct; 34(4 Suppl 5):9-19. PubMed ID: 9408956 [TBL] [Abstract][Full Text] [Related]
12. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447 [TBL] [Abstract][Full Text] [Related]
13. The interactive transcript abundance index [c-myc*p73alpha]/[p21*Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines. Harr MW; Willey JC Int J Oncol; 2007 Jun; 30(6):1553-60. PubMed ID: 17487378 [TBL] [Abstract][Full Text] [Related]
14. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Lê MG; Mathieu MC; Douc-Rasy S; Le Bihan ML; Adb El All H; Spielmann M; Riou G Int J Cancer; 1999 Dec; 84(6):562-7. PubMed ID: 10567899 [TBL] [Abstract][Full Text] [Related]
15. The expression of oncogenes in tumour tissues of breast carcinoma patients. Rzymowska J; Grzybowska-Szatkowska L Folia Histochem Cytobiol; 2001; 39 Suppl 2():93-5. PubMed ID: 11820644 [TBL] [Abstract][Full Text] [Related]
16. Cell death regulation during multistep lymphomagenesis. Hsu B; Marin MC; McDonnell TJ Cancer Lett; 1995 Jul; 94(1):17-23. PubMed ID: 7621440 [TBL] [Abstract][Full Text] [Related]
18. A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line. Supino R; Perego P; Gatti L; Caserini C; Leonetti C; Colantuono M; Zuco V; Carenini N; Zupi G; Zunino F Eur J Cancer; 2001 Nov; 37(17):2247-56. PubMed ID: 11677115 [TBL] [Abstract][Full Text] [Related]
19. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of bcl-2, c-myc, and Fas expression during tricyclic antidepressant-induced apoptosis in human peripheral lymphocytes. Xia Z; DePierre JW; Nässberger L J Biochem Toxicol; 1996; 11(4):203-4. PubMed ID: 9062851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]